Collplant Biotechnologies Lt

Penny Stocks Biotech Stocks Healthcare Stocks

$0.35

-0.02 (-4.83%)

As of Jun 30, 10:53 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +4,826.9% upside

Low Target $14.35

Average Target $17.19

High Target $29.92

Current Price $0.35

Current
$0.35

Target
$17.19

$14.35 $17.19 avg $29.92

Scenario Analysis

Bear Case

$14.35

4,012.9%

Low target

Base Case

$17.19

+4,826.9%

Avg target

Bull Case

$29.92

+8,475.5%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$3.23

-89.2% from high

52-Week Low

$0.27

+28.7% from low

Target vs 52W High

$17.19

+431.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%